AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia, as well as novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

Contact Information

125 Cambridgepark Drive
6th Floor
Cambridge, MA 02140

tel: 617-498-3300
fax: 617-499-3361


Investor Relations



Exchange: NASDAQ
Industry: Diagnostic Substances
Market Cap: $670.7M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.